Stable
Ischemic
Heart Disease

CARDIOLOGY SOLUTIONS

Managing risk factors and follow up for patients with Stable Ischemic Heart Disease is critical. GE Healthcare’s Cardiovascular IT and Diagnostic Cardiology solutions can provide insights throughout the cardiology care pathway to help improve clinical decisions and outcomes.
Early detection and management including counseling, and medical therapy are important for patients with cardiovascular disease or who are at a high risk, including those with risk factors such as hypertension, diabetes, and high cholesterol.1

The Patient Journey

diagnosis & risk stratification
Non-invasive methods for observing response to guideline-directed therapy can be employed, two examples of these methods are 12 SL ECG interpretation and stress imaging. Additionally, if the patient is not responsive to therapy, CT, MR or Nuclear studies may help show functional degradation which might necessitate a follow on intervention such as PCI or CABG.
intervention
Successful PCI of the stenotic lesions involves planning, guidance, and assessment of the culprit lesion and assessment of the remainder of the coronary tree.
patient follow-up and monitoriing
Follow-up treatment and rehabilitation strategy can include behavior modification and medical therapy in addition to monitoring cardiac function non-invasively using ALARA principles.
digital foundation and innovations
Digital solutions, analytics and AI innovations such as GE Healthcare's Edison Platform, Muse and Centricity Cardio Enterprise connect our wing-to-wing technologies to practitioners for better cardiology outcomes, more efficiently.

  • The latest in Cardiology


    INSIGHTS THE PULSE
references

JB66440XX

WIPRO GE HEALTHCARE PVT LTD
No. 4, Kadugodi Industrial Area,
Bangalore 560067,
Karnataka, India
CIN: U33111KA1990PTC01606